Recovery
TB-500 is a synthetic peptide related to thymosin beta-4, a protein found throughout the body. At RxPepLab it is available only by prescription, after a licensed provider's review.
Thymosin beta-4 is a 43-amino-acid protein present in most human cells, where it helps regulate actin, a building block of the cell's internal scaffolding. TB-500 is a synthetic peptide based on the active region of thymosin beta-4.
Research has looked at thymosin beta-4 in tissue and wound models, mostly in animals. Human data on TB-500 are limited, and it is not FDA-approved for any use.
Check out
Choose your protocol and pay securely.
Complete your intake
Tell us about your health history, medications and goals.
Provider review
A licensed medical provider reviews your intake, usually within 48 hours, and decides whether TB-500 is appropriate. If it isn't, you're refunded.
Pharmacy fills and ships
A licensed U.S. compounding pharmacy prepares your prescription and ships it discreetly.
TB-500 and thymosin beta-4 are prohibited in competitive sport by the World Anti-Doping Agency (WADA). If you are a tested athlete, tell your provider.
TB-500 does not replace evaluation of an injury. Your provider may recommend in-person care or imaging first.
Yes. TB-500 is available at RxPepLab only by prescription, after a licensed medical provider reviews your intake.
No. Compounded medications are prepared for an individual patient by a licensed pharmacy. They are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality.
$249 for a one-month supply, which includes your provider review. Members get free shipping on every order.
Not exactly. Thymosin beta-4 is the full natural protein. TB-500 is a synthetic peptide based on part of it.
Compounded medications are not approved by the FDA and have not been evaluated by the FDA for safety, effectiveness or quality. All prescriptions require evaluation and approval by a licensed healthcare provider. Information on this site is educational and is not medical advice.
RELATED